Invention Grant
- Patent Title: Hydroxystatin derivatives for the treatment of arthrosis
-
Application No.: US15364598Application Date: 2016-11-30
-
Publication No.: US10077288B2Publication Date: 2018-09-18
- Inventor: Christos Tsaklakidis , Markus Klein
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen White Zelano and Branigan, PC
- Agent John Sopp
- Priority: EP12005379 20120724
- Main IPC: A61K38/05
- IPC: A61K38/05 ; C07K5/08 ; C07K5/02 ; A61K38/06 ; C07K5/06 ; A61K38/00

Abstract:
The present invention relates to compounds of the formula (I) and in particular to medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries arthritis, pain, allodynia or hyperalgesia.
Public/Granted literature
- US20170081361A1 HYDROXYSTATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS Public/Granted day:2017-03-23
Information query
IPC分类: